Aspreva Pharmaceuticals Corporation To Present At The CIBC World Markets Institutional Investor Conference In Whistler, B.C.

VICTORIA, Feb. 6 /PRNewswire-FirstCall/ - Aspreva Pharmaceuticals Corporation today announced that Bruce Cousins, Chief Financial Officer, will be presenting at the CIBC World Markets Institutional Investor Conference in Whistler, B.C.

The 30 minute presentation will be followed by a 30 minute break out session and will take place on Thursday, February 16th at 8:35 am PST at the Westin Resort & Spa.

A live audio web cast of Mr. Cousins' presentation will be available to all interested parties through a link posted on Aspreva's website at www.aspreva.com in the Investors section.

About Aspreva Pharmaceuticals

Aspreva is an emerging pharmaceutical company focused on identifying, developing and, upon regulatory approval, commercializing new indications for approved drugs and late stage drug candidates for patients living with less common diseases. Aspreva's "Indication Partnering" strategy allows its partners to maintain core brand focus while extending the benefits of their medicines to a broader patient population. Aspreva is listed on the Nasdaq National Market under the trading symbol "ASPV" and on the Toronto Stock Exchange under the trading symbol "ASV".

For further information please contact: Sage Baker Executive Director, Corporate & Investor Affairs Aspreva Pharmaceuticals 250-744-2488 ext. 270 sbaker@aspreva.com

CONTACT: Sage Baker, Executive Director, Corporate & Investor Affairs,Aspreva Pharmaceuticals, (250) 744-2488 ext. 270, sbaker@aspreva.com